金利來集團(00533.HK):建議及計劃失效 12日復牌
格隆匯5月9日丨金利來集團(00533.HK)公告,於2025年5月9日舉行的法院會議上,批準計劃的決議案未獲親身或委派代表出席法院會議並於會上投票的計劃股東批準。
由於計劃並無根據公司條例及收購守則的規定於法院會議上獲得批準,因此(i)建議及計劃已告失效,建議將不會實施,而計劃將不會具有約束力及生效;(ii)股份於聯交所的上市地位將不會撤銷;及(iii)公司將不會自2025年6月23日起暫停辦理股份過戶登記手續,以釐定計劃股東於計劃項下的權利。
董事會認爲,建議及計劃失效將不會對集團的業務、營運或財務狀況造成任何重大不利影響。
公司已向聯交所申請股份於2025年5月12日上午九時正起恢復買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.